![3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile structure, CAS 1092578-46-5](/structures/210000/181108_1_1092578_46_5.png)
CAS Number1092578-46-5
Synonyms(3R,4S)-Tofacitinib|; CS-1109; 1-Piperidinepropanenitrile,4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)--oxo-,(3R,4S); 3-((3R,4S)-3-((1H-Indol-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropan-enitrile; (3R,4S)-Tofacitinib
Molecular FormulaC16H20O1N6
Molecular Weight312.37
Density1.3±0.1 g/cm3
Boiling Point585.8±50.0 °C at 760 mmHg
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 1092578-46-5 |
| Catalog No. | 2A-3180278 |
| Chinese Name | (3R,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-d]嘧啶-4-氨基)-beta-氧代-1-哌啶丙腈 |
| Synonyms | (3R,4S)-Tofacitinib|; CS-1109; 1-Piperidinepropanenitrile,4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)--oxo-,(3R,4S); 3-((3R,4S)-3-((1H-Indol-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropan-enitrile; (3R,4S)-Tofacitinib |
| Molecular Formula | C16H20O1N6 |
| Molecular Weight | 312.37 |
| Density | 1.3±0.1 g/cm3 |
| Boiling Point | 585.8±50.0 °C at 760 mmHg |
| Storage Condition | -20°C |
| Application | Tofacitinib (CP-690550) is a highly effective JAK3 inhibitor with an IC50 of 1 nM, which is 20 times and 100 times more potent than JAK2 and JAK1. |
| PubChem ID | 57286363 |
| MDL Number | MFCD23160057 |
| SMILES | CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12 |
| InChI | InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13-/m0/s1 |
| InChI Key | UJLAWZDWDVHWOW-AAEUAGOBSA-N |
| Transport Info | Product Name: (3R,4S)-Tofacitinib |
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA